Details of the Target
General Information of Target
Target ID | LDTP00457 | |||||
---|---|---|---|---|---|---|
Target Name | Free fatty acid receptor 1 (FFAR1) | |||||
Gene Name | FFAR1 | |||||
Gene ID | 2864 | |||||
Synonyms |
GPR40; Free fatty acid receptor 1; G-protein coupled receptor 40 |
|||||
3D Structure | ||||||
Sequence |
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLP
LKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRP CYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAG PARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPY NASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK |
|||||
Target Type |
Clinical trial
|
|||||
Target Bioclass |
GPCR
|
|||||
Family |
G-protein coupled receptor 1 family
|
|||||
Subcellular location |
Cell membrane
|
|||||
Function |
G-protein coupled receptor for medium and long chain saturated and unsaturated fatty acids that plays an important role in glucose homeostasis. Fatty acid binding increases glucose-stimulated insulin secretion, and may also enhance the secretion of glucagon-like peptide 1 (GLP-1). May also play a role in bone homeostasis; receptor signaling activates pathways that inhibit osteoclast differentiation. Ligand binding leads to a conformation change that triggers signaling via G-proteins that activate phospholipase C, leading to an increase of the intracellular calcium concentration. Seems to act through a G(q) and G(i)-mediated pathway. Mediates the anti-inflammatory effects of omega-3 polyunsaturated fatty acids (PUFAs) via inhibition of NLRP3 inflammasome activation.
|
|||||
TTD ID | ||||||
Uniprot ID | ||||||
DrugMap ID | ||||||
Ensemble ID | ||||||
HGNC ID | ||||||
ChEMBL ID |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
IPM Probe Info |
![]() |
C289(3.42) | LDD2229 | [1] | |
BTD Probe Info |
![]() |
C289(0.95) | LDD2143 | [2] |
Competitor(s) Related to This Target
References